Gastrointestinal microbiome, containing at least 100 trillion bacteria, resides in the mucosal
surface of human intestine. Recent studies show that perturbations in the microbiota may …

Available evidence on the bioactive, nutritional and putative detrimental properties of gut
microbial metabolites has been evaluated to support a more integrated view of how …

Simple Summary Colorectal cancer (CRC) is the second-leading cause of cancer-related
deaths worldwide. In this review article, we examine the role of gut microbiota in the …

Increased risk of colorectal cancer (CRC) is associated with altered intestinal microbiota as
well as short‐chain fatty acids (SCFAs) reduction of output The energy source of colon cells …

Inflammatory Bowel Disease (IBD) represents a group of idiopathic disorders characterized
by chronic or recurring inflammation of the gastrointestinal tract. While the exact etiology of …

Colorectal cancer (CRC) is a leading cause of preventable cancer deaths worldwide, with
dietary factors being recognised as key risk modifiers. Foods containing dietary fibre are …

The intestinal microbiota is well known to have multiple benefits on human health, including
cancer prevention and treatment. The effects are partially mediated by microbiota-produced …

Butyrate is one of the short chain fatty acids, produced by the gut microbiota during
anaerobic fermentation of dietary fibres. It has been shown that it can inhibit tumor …

Recent studies have highlighted a myriad of ways in which the activity and composition of
the gut microbiota can affect the host organism. A primary way in which the gut microbiota …

A number of recent studies have begun to explore a new and exciting area: the interaction
between the gut microbiome and renal physiology. In particular, multiple studies have …